BlueStar Genomic Health Care Index

The BlueStar Genomic Health Care Index (BDNANTR) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.

Country and Sector Weightings

MVIS Sector Indices are pure-play sector indices. Companies must generate at least 50% of their revenues in the target sector to be eligible for index inclusion. Country and Sector weightings are based on the weightings of all index components in a certain country or sector.

CountryComponentsWeight
Canada1 1.01%
United States62 77.79%
Belgium1 0.91%
France2 2.08%
Germany3 3.72%
Netherlands1 0.98%
Switzerland1 1.14%
United Kingdom4 5.54%
Israel1 1.09%
Japan2 1.94%
New Zealand1 1.60%
China2 2.22%
Total81 100.00%
SectorComponentsWeight
Health Care81 100.00%
Total81 100.00%

Size Weightings

  • Large-Cap: companies with a market capitalisation above 6,000 mln USD
  • Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln USD
  • Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln USD
  • Micro-Cap: companies with a market capitalisation up to 200 mln USD
SizeMarket CapComponentsWeight
Large-Cap537,728,752,000 USD20 28.89%
Mid-Cap81,249,389,400 USD26 34.49%
Small-Cap30,349,343,640 USD35 36.61%
Micro-Cap---
Total649,327,485,040 USD81 100.00%
Up